From Name

From Email

To Name

To Email

Message

Novel pediatric disease risk index in patients with ALL, AML for allogeneic hematopoietic cell transplantation

from Hematology Advisor

Novel pediatric disease risk index in patients with ALL, AML for allogeneic hematopoietic cell transplantation Hematology Advisor Researchers have developed a validated pediatric disease risk index (p-DRI) for acute myeloid (AML) and acute lymphoblastic leukemia (ALL) that successfully stratifies children undergoing allogeneic hematopoietic cell transplantation for prognostication. READ MORE

more